BYTES

G8 and tragedy of Africa

Rich nations are forcing African states to change laws to facilitate private investment in agriculture in a replay of colonial adventurism

Canada, Australia questioned over low emissions reduction targets

Other developed countries kept mum as questioning progressed at the Bonn conference

Corals, maths and satellites

A new mathematical formula will scan satellite images to study changes in coral reefs

7th GEF Assembly: Member countries get together to ratify Global Biodiversity Framework Fund 

Momentum set in Vancouver crucial for achieving the biodiversity and sustainable development goals by 2030

Ontario gets rid of coal-fired power

Air quality in the Canadian province has been improving because of a mix of emissions-free electricity sources

It’s still open season for bio-piracy

Rich nations block accord on benefit-sharing rules for the world’s genetic resources

22 million people displaced by natural disasters globally last year

Floods, storms and quakes displaced 19 million people in Asia alone

News 360°

G8, developing countries launch Potsdam Initiative

Brief

Compromising on climate

Jan Pronk, chairperson of climate change talks held in New York, offers a compromise plan that gives away too much on sinks

A sticky label

US biotech industry gears up to play dirty in Europe

News 360°- Briefs

In the wrong ministry?

Biotech Regulatory Authority will have too much power, no checks

France extends GM corn ban

Science and Technology - Briefs

Fruitful deliberations

Two global meetings chart a course for weeding out biopiracy

Arctic rush driven by desire to control hydrocarbon deposits, shipping routes

Scientists discover natural gas off the east coast of Canada

Patent issues delaying Ebola cure

Canada's exclusive licensing rights of its Ebola patent to a US firm are holding up global development of a vaccine

In Short

Bad chemistry

Asbestos, agribusiness get a leg up

Science & Technology - Briefs

Predatory EU pacts

EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global